Paul Johnson, PhD, MBA, DABCC

Paul Johnson, PhD, MBA, DABCC
Appointed 08/16/12
3260B Weiskotten Hall
766 Irving Ave.
Syracuse, NY 13210

315 464-5337

Current Appointments

Hospital Campus

Education & Fellowships

  • PhD: University of Louisville School of Medicine, 2011, Biochemistry, Molecular Biology
  • MBA: University of Illinois at Chicago, 2004

Clinical Interests

  • Vitamin D, Concussion biomarkers

Research Interests

  • Vitamin D, Concussion biomarkers

Specialties & Certification

  • Medical Technology (MT) (ASCP)
  • Clinical Chemistry (ABCC)


  • American Society for Clinical Pathology
  • American Association for Clinical Chemistry, Upstate New York Regional Chairman


Link to PubMed External Icon (Opens new window. Close the PubMed window to return to this page.)


Dr. Paul Johnson began his professional career as a clinical laboratory scientist. He later earned a doctorate in Biochemistry & Molecular Biology from the University of Louisville Medical School. Dr Johnson is board certified both as a medical technologist (American Society for Clinical Pathology, ASCP) and a clinical chemist (American Board of Clinical Chemistry Diplomate, DABCC).  He teaches courses in clinical biochemistry and statistics within the field of pathology and laboratory medicine.

As a research investigator on two current projects, Dr. Johnson is studying the human metabolome in Vitamin D-deficient subjects by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) analysis. He is also co-investigator of a study to determine diagnostic utility of serum biomarkers of concussion in human subjects with a goal of improving early diagnosis.

Recent Publications

  • Wu R, Kausar H, Johnson P, Montoya-Durango DE, Merchant M, Rane MJ. Hsp27 regulates Akt activation and polymorphonuclear leukocyte apoptosis by scaffolding MK2 to Akt signal complex. J. Biol. Chem. 2007; 282(30):21598-608.
  • Johnson PR. Down-regulation of bile acid synthesis and a metabolic co-activator under hypoxic conditions - implications in obstructive sleep apnea. Med Hypotheses. 2008;71(4):530-536.
  • El Haibi CP, Sharma PK, Singh R, Johnson PR, Suttles J, Singh S, Lillard JW Jr. PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells. Mol Cancer. 2010 Apr 22;9(1):85.
  • Johnson PR, Shah PP, Barati MT, Gozal E, Rane MJ. Molecular chaperones: ubiquitous proteins with great diversity of function in health and disease. Current Topics in Biochemical Research. 2015; 16: 53-65.
  • Kufel WD, Miller CD, Johnson PR, Reid K, Zahra JJ, Seabury RW. Y-site incompatibility between premix concentrations of vancomycin and piperacillin-tazobactam: Do current compatibility testing methodologies tell the whole story? Hosp Pharm 2017;52:132-7.
  • Johnson PR, Gwilt SC, Neville CG. Estimates of Within-Person Biological Variation and Reference Change Values of Serum S100B and NSE Proteins. Clin Chem. 2018 Feb 26. pii: clinchem.2017.285973. doi:10.1373/clinchem.2017.285973. [Epub ahead of print]

Recent Abstracts

  • Johnson PR, Neville CG. Evaluation of serum biomarker assays for mild traumatic brain injury in a cohort of mixed martial arts fighters. American Association for Clinical Chemistry (AACC) Annual Meeting, August 2016, Philadelphia, PA.
Faculty Profile Shortcut: http://www.upstate.edu/faculty/johnspau